LKQ Posts 1.9 Percent Revenue Drop in Q2

LKQ reported Q2 2025 adjusted diluted EPS of $0.87, missing estimates and marking an 11.2% year-over-year decline, alongside a 1.9% GAAP revenue decrease to $3.64 billion. Citing persistent demand weakness in North America and Europe, exacerbated by reduced repairable insurance claims, and ongoing margin pressures, the company significantly lowered its full-year 2025 guidance for revenue and earnings. Despite ongoing cost-cutting and portfolio streamlining efforts, the revised outlook reflects challenging market conditions requiring a material improvement in end-market demand for a positive shift in performance.

Analysis

LKQ Corporation reported a challenging second quarter for fiscal 2025, marked by deteriorating fundamentals and a significant downward revision to its full-year outlook. The company's adjusted diluted EPS of $0.87 not only missed the consensus estimate of $0.92 but also represented an 11.2% year-over-year decline. This was accompanied by a 1.9% drop in GAAP revenue to $3.64 billion, driven by a 3.4% contraction in organic parts and services revenue. Management attributed the weakness to persistent demand softness in its core North American and European markets, highlighted by a 9% industry-wide reduction in repairable insurance claims in North America. Profitability suffered from negative operating leverage, with segment EBITDA margins contracting to 15.8% in North America and 9.4% in Europe, and consolidated SG&A expenses rising to 27.4% of sales. Despite management's cost-cutting initiatives and portfolio simplification, a notable rise in inventory to $3.39 billion amidst falling sales signals potential working capital inefficiencies. The revised full-year 2025 guidance, now projecting an organic revenue decline of 1.5% to 3.5% and adjusted EPS of $3.00–$3.30, underscores the severity of the headwinds facing the company.

Key Decisions for Investors

• Given the significant downward revision to full-year guidance and persistent demand weakness in core markets, investors should re-evaluate any bullish thesis tied to a near-term operational turnaround.
• Monitor progress on the European restructuring and SKU rationalization programs, as their success is critical for stabilizing declining organic revenue and compressed EBITDA margins.
• Closely watch working capital management, particularly the elevated inventory level of $3.39 billion, as a failure to reduce it in line with sales could further pressure free cash flow and profitability.
• Weigh the company's commitment to capital returns, including its dividend and $39 million in Q2 share repurchases, against the clear deterioration in operational performance and market conditions before adjusting positions.